Big Pharma Turns to AI to Speed Drug Discovery, GSK Signs Deal by REUTERS


By REUTERS

The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million (£33 million) deal in the field on Sunday….

Published: July 2, 2017 at 03:06AM

from NYT Business Day http://ift.tt/2tCV4ID
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s